WinstonWınston
Back
Atlas Arteria Limited logo

Atlas Arteria Limited

ALX.AX
38
Industrial - Infrastructure Operations · Industrials
Price
A$4.82
-0.02 (-0.41%)
Market Cap
A$7.01B
Exchange
Australian Securities Exchange
Winston Score
38
Winston is serious
Below-average fundamentals — multiple weak pillars.
Data as of Aug 23, 2026 · filings through Dec 31, 2025
How the score breaks down
Quality
Weak
Growth
Weak
Cash Flow
Exceptional
Stability
Good
Valuation
Good
Dividends
Good

Winston Score History

The full picture

Atlas Arteria is an Australian company that owns and operates toll roads in Europe and North America. Its main assets are long-term concessions on major highways, meaning it has the right to collect tolls from drivers for decades. The company's largest asset is APRR, a large toll road network in France that handles millions of vehicle trips each year.

Atlas Arteria makes money by charging drivers a fee every time they use one of its roads. Most of its revenue comes from France, with smaller operations in the United States. The business benefits from a strong moat because toll road concessions are government-granted monopolies — competitors cannot simply build a rival road nearby. However, the company carries significant debt, which is common in infrastructure, and rising interest rates increase its borrowing costs. The key risk going forward is managing that debt load while concession agreements eventually approach their expiry dates.

Share count broadly stable

+0.2% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 1.45B (2021) → 1.45B (2025)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
2.2%
Thin — 2.2% gross margin
Profit after running costs
Operating Margin
-15.5%
Losing money on operations — -15.5%
Return on the money invested
ROCE
0.2%
Weak — 0.2% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-16.4%
Shrinking sales (-16.4% YoY)
Profit growth
EPS YoY
-22.1%
Earnings shrinking (-22.1% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is
EPS Consistency
3/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
148%
Turns 148% of profit into real cash
Spare cash per sale
FCF Margin
251.2%
Converts sales into free cash efficiently (251.2%)

Free cash flow margin above 20%. Out of every $100 in sales, more than $20 is real cash they keep.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.30
Conservative — low debt load (0.30)
Covers its interest
Interest Cover
0.12x
Dangerous — barely covers interest (0.1x)

Interest coverage below 1. Their profits don't cover the interest bill.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
32.8x
Pricey — P/E 32.8

P/E above the market average. People are paying up for expected growth.

Cheaper or dearer next year
P/E vs Forward
+18.3
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (32.8 → 14.5)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
8.06%
Healthy income — 8.06% yield

Yield above 6% — often a flag the market is pricing in a cut.

Dividend record
Dividend Growth
+0.0%
Dividend flat

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial